Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 3
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2015 1
2017 3
2018 2
2019 1
2020 6
2021 5
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
CIC-DUX4 sarcomas.
Brahmi M, Vanacker H, Macagno N, Tirode F, Dufresne A. Brahmi M, et al. Among authors: vanacker h. Curr Opin Oncol. 2022 Jul 1;34(4):342-347. doi: 10.1097/CCO.0000000000000855. Epub 2022 Jun 22. Curr Opin Oncol. 2022. PMID: 35730520 Review.
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.
Fazel M, Dufresne A, Vanacker H, Waissi W, Blay JY, Brahmi M. Fazel M, et al. Among authors: vanacker h. Cancers (Basel). 2023 Mar 7;15(6):1643. doi: 10.3390/cancers15061643. Cancers (Basel). 2023. PMID: 36980528 Free PMC article. Review.
[New therapeutic strategies in HER2-positive breast cancer].
Mery B, Toussaint P, Heudel PE, Dufresne A, Carbonnaux M, Vanacker H, Bachelot T, Trédan O. Mery B, et al. Among authors: vanacker h. Bull Cancer. 2021 Jun 15:S0007-4551(21)00215-0. doi: 10.1016/j.bulcan.2021.04.015. Online ahead of print. Bull Cancer. 2021. PMID: 34144793 Review. French.
Rare ovarian tumors: an update on diagnosis and treatment.
Debuquoy C, Romeo C, Vanacker H, Ray-Coquard I. Debuquoy C, et al. Among authors: vanacker h. Int J Gynecol Cancer. 2020 Jun;30(6):879-887. doi: 10.1136/ijgc-2020-001235. Epub 2020 May 26. Int J Gynecol Cancer. 2020. PMID: 32461259 Review.
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Vanacker H, Treilleux I, Schiffler C, Bieche I, Campone M, Patsouris A, Arnedos M, Cottu PH, Jacquin JP, Dalenc F, Pinton A, Servant N, Attignon V, Rouleau E, Morel A, Legrand F, Jimenez M, Andre F, Bachelot T. Vanacker H, et al. Br J Cancer. 2024 Mar;130(4):613-619. doi: 10.1038/s41416-023-02549-8. Epub 2024 Jan 5. Br J Cancer. 2024. PMID: 38182687
41 results